why choose us

First received: July 10, 2025

Clinical Trial: Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Myelodysplastic Syndromes

Study Type: OBSERVATIONAL


Official Title: Real-World Treatment Patterns and Outcomes of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes (LR-MDS) in China ('REACH' Study)

Brief Summary: The purpose of this study is to evaluate the treatment patterns and clinical outcomes in adults with lower-risk MDS (LR-MDS) who were erythropoiesis-stimulating agents (ESA)-naïve and received luspatercept treatment in China

Read more